Please login to the form below

Not currently logged in
Email:
Password:

Eric Terhaerdt leaves AZ for Astellas

Joins as senior VP of global development operations

Eric Terhaerdt, AstellasAstellas has turned to AstraZeneca for its new senior VP of global development operations.

Eric Terhaerdt spent more than 20 years at AZ, most recently serving as VP, head of scientific and technical evaluations.

He will now lead the global direction of the drug development operations at Japan-based Astellas, working primarily in the Netherlands and the US.

Terhaerdt has extensive knowledge of the global pharmaceutical market having worked across the world for AZ in countries such as the UK, the US, Sweden, Hungary and the Czech Republic.

Dr Bernie Zeiher, executive VP, global development, welcomed Terhaerdt to the company: "His diverse international experience in drug development, strategic planning and change management will help Astellas continue to address the unmet needs of our patients."

20th January 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics